XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative effect adjustment for the adoption of ASC 326
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative effect adjustment for the adoption of ASC 326
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance at Dec. 31, 2021 $ 211,455     $ 53   $ 46,901   $ 188,877     $ (17,846)   $ (6,530)  
Increase (Decrease) in Shareholders' Equity [Roll Forward]                            
Net income 14,891             14,891            
Other comprehensive loss (48,815)                       (48,815)  
Restricted stock awards 333         333                
Restricted stock units for directors' deferred compensation plan 100         100                
Distribution of shares of treasury stock grants for employee restricted stock awards 0         (112)         112      
Cash dividends declared (2,898)             (2,898)            
Distribution of treasury stock for directors' compensation 105         (139)         244      
Repurchase of shares of common stock (695)                   (695)      
Sale of shares of treasury stock [1] 216         83         133      
Forfeitures of shares of restricted stock awards (2)         30         (32)      
Ending balance at Jun. 30, 2022 174,690     53   47,196   200,870     (18,084)   (55,345)  
Beginning balance at Dec. 31, 2021 211,455     53   46,901   188,877     (17,846)   (6,530)  
Ending balance at Dec. 31, 2022 $ 166,388 $ (1,076) $ 165,312 53 $ 53 47,331 $ 47,331 211,859 $ (1,076) $ 210,783 (17,598) $ (17,598) (75,257) $ (75,257)
Increase (Decrease) in Shareholders' Equity [Roll Forward]                            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]                          
Beginning balance at Mar. 31, 2022 $ 185,510     53   46,880   194,295     (18,113)   (37,605)  
Increase (Decrease) in Shareholders' Equity [Roll Forward]                            
Net income 8,024             8,024            
Other comprehensive loss (17,740)                       (17,740)  
Restricted stock awards 154         154                
Restricted stock units for directors' deferred compensation plan 95         95                
Cash dividends declared (1,449)             (1,449)            
Sale of shares of treasury stock [1] 98         37         61      
Forfeitures of shares of restricted stock awards (2)         30         (32)      
Ending balance at Jun. 30, 2022 174,690     53   47,196   200,870     (18,084)   (55,345)  
Beginning balance at Dec. 31, 2022 166,388 $ (1,076) $ 165,312 53 $ 53 47,331 $ 47,331 211,859 (1,076) $ 210,783 (17,598) $ (17,598) (75,257) $ (75,257)
Increase (Decrease) in Shareholders' Equity [Roll Forward]                            
Net income 13,550             13,550            
Other comprehensive loss 511                       511  
Restricted stock awards 548         548                
Restricted stock units for directors' deferred compensation plan 10         10                
Distribution of shares of treasury stock grants for employee restricted stock awards 0         (131)         131      
Cash dividends declared (2,921)             (2,921)            
Distribution of treasury stock for directors' compensation 96         (147)         243      
Repurchase of shares of common stock (98)                   (98)      
Sale of shares of treasury stock [1] 419         118         301      
Forfeitures of shares of restricted stock awards (1)         11         (12)      
Ending balance at Jun. 30, 2023 177,426     53   47,740   221,412     (17,033)   (74,746)  
Beginning balance at Mar. 31, 2023 177,342     53   47,387   216,594 $ (1,100)   (17,219)   (69,473)  
Increase (Decrease) in Shareholders' Equity [Roll Forward]                            
Net income 6,280             6,280            
Other comprehensive loss (5,273)                       (5,273)  
Restricted stock awards 285         285                
Restricted stock units for directors' deferred compensation plan 5         5                
Cash dividends declared (1,462)             (1,462)            
Sale of shares of treasury stock [1] 250         52         198      
Forfeitures of shares of restricted stock awards (1)         11         (12)      
Ending balance at Jun. 30, 2023 $ 177,426     $ 53   $ 47,740   $ 221,412     $ (17,033)   $ (74,746)  
[1] All treasury stock sales were completed at the prevailing market price with the Chemung Canal Trust Company Profit Sharing, Savings, and Investment Plan which is a defined contribution plan sponsored by the Bank.